Personalis, Inc.

Personalis, Inc. is a biotechnology company focused on revolutionizing cancer care through personalized testing. Founded in 2011 by a team of experts from Stanford University, the company is dedicated to developing cutting-edge genomic tests that detect minimal residual disease (MRD), predict recurrence, and guide personalized treatment strategies. Personalis' mission is to transform the active management of cancer by providing clinicians and patients with ultra-sensitive and accurate insights into the complex landscape of individual tumors.

Personalis operates a state-of-the-art, CLIA-certified and CAP-accredited laboratory equipped with advanced sequencing technologies and proprietary algorithms. The company offers a suite of products, including NeXT Personal Dx for MRD detection, NeXT Dx for comprehensive tumor profiling, and ImmunoID NeXT for multidimensional tumor sequencing and analysis. Through its collaborations with leading academic institutions and biopharmaceutical companies, Personalis is actively contributing to the development of next-generation cancer therapies and diagnostics.

Personalis offers a comprehensive benefits package to its employees, including medical, dental, and vision insurance, a 401(k) plan with matching contributions, an employee stock purchase plan (ESPP), tuition reimbursement, sick and vacation time, commuter benefits and EV charging stations, an onsite gym, and wellness benefits.

Personalis, Inc. is a company dedicated to transforming the active management of cancer through breakthrough personalized testing. They strive to build a world where personalized testing provides greater confidence and exceptional outcomes for cancer patients. They focus on developing advanced genomic tests that detect ultra-low traces of minimal residual disease (MRD) and recurrence, uncover deeper insights for therapy selection, and power the design of individualized neoantigen therapies.

Personalis promotes a culture built on passion, integrity, and teamwork. They value scientific excellence and innovation while fostering a respectful and inclusive workplace. The company recognizes the unique contributions of each employee and emphasizes the importance of collaboration and shared success in advancing the field of precision oncology.

Personalis embraces diversity, equity, and inclusion as core values, recognizing the unique perspectives of each individual and striving to foster an inclusive workplace that welcomes, encourages, supports, and celebrates diverse voices and experiences. They believe that diversity contributes to the success of both employees and the company, and they are committed to providing reasonable accommodations to those with disabilities.